ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed GlioblastomaManmeet Ahluwalia,David Reardon,Ajay Abad,William Curry,Eric Wong,David Peereboom,Ahmed Belal,Jingxin Qiu,Kathleen Mogensen,Cathy Schilero,Danielle Casucci,Laszlo Mechtler,Erik Uhlmann,Michael Ciesielski,Robert FenstermakerNeuro-oncology(2018)引用 9|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要